Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Rodrigues

Showing results (171-180 of 194) with videos related to

Pageof 20
Sort By:
Acta Medica Portuguesa|March 22, 2019
Chronic Urticaria in the Real-Life Clinical Practice Setting in Portugal: Baseline Results from the Non-Interventional Multicentre AWARE StudyCélia Costa, Isabel Rosmaninho, Arminda Guilherme, et al.
Arthritis Care & Research|October 30, 2014
Using the Juvenile Arthritis Disease Activity Score based on erythrocyte sedimentation rate or C-reactive protein level: results from the Portuguese registerAna F Mourão, Maria J Santos, José Melo-Gomes, et al.
Breast (Edinburgh, Scotland)|February 20, 2024
Single-agent metronomic versus weekly oral vinorelbine as first-line chemotherapy in patients with HR-positive/HER2-negative advanced breast cancer: The randomized Tempo Breast studyGilles Freyer, Noelia Martinez-Jañez, Bożena Kukielka-Budny, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 6, 2026
Machine Learning to Predict Remission Between Six and 24 Months in Rheumatoid Arthritis: Insights from the JAK-pot CollaborationZubeyir Salis, Denis Mongin, Denis Choquette, et al.
Rheumatology (Oxford, England)|December 18, 2015
Effectiveness and long-term retention of anti-tumour necrosis factor treatment in juvenile and adult patients with juvenile idiopathic arthritis: data from Reuma.ptAna F Mourão, Maria J Santos, José A Melo Gomes, et al.
Acta Reumatologica Portuguesa|July 12, 2012
Portuguese recommendations for the use of biological therapies in patients with axial spondyloarthritis--December 2011 updatePedro Machado, Alexandra Bernardo, Ana Rita Cravo, et al.
Annals of the Rheumatic Diseases|September 13, 2022
After JAK inhibitor failure: to cycle or to switch, that is the question - data from the JAK-pot collaboration of registriesManuel Pombo-Suarez, Carlos Sanchez-Piedra, Juan Gómez-Reino, et al.
Annals of the Rheumatic Diseases|May 30, 2024
Factors associated with disease flare following SARS-CoV-2 vaccination in people with inflammatory rheumatic and musculoskeletal diseases: results from the physician-reported EULAR Coronavirus Vaccine (COVAX) RegistryBayram Farisogullari, Saskia Lawson-Tovey, Kimme L Hyrich, et al.
RMD Open|November 3, 2024
Impact of patient characteristics on ASDAS disease activity state cut-offs in axial spondyloarthritis: results from nine European rheumatology registriesLykke M Ørnbjerg, Stylianos Georgiadis, Tore K Kvien, et al.
RMD Open|November 8, 2018
Mixed connective tissue disease: state of the art on clinical practice guidelinesBenjamin Chaigne, Carlo Alberto Scirè, Rosaria Talarico, et al.
Pageof 20

Showing results (171-180 of 194) with videos related to

Sort By:
Pageof 20
Acta Medica Portuguesa|March 22, 2019
Chronic Urticaria in the Real-Life Clinical Practice Setting in Portugal: Baseline Results from the Non-Interventional Multicentre AWARE StudyCélia Costa, Isabel Rosmaninho, Arminda Guilherme, et al.
Arthritis Care & Research|October 30, 2014
Using the Juvenile Arthritis Disease Activity Score based on erythrocyte sedimentation rate or C-reactive protein level: results from the Portuguese registerAna F Mourão, Maria J Santos, José Melo-Gomes, et al.
Breast (Edinburgh, Scotland)|February 20, 2024
Single-agent metronomic versus weekly oral vinorelbine as first-line chemotherapy in patients with HR-positive/HER2-negative advanced breast cancer: The randomized Tempo Breast studyGilles Freyer, Noelia Martinez-Jañez, Bożena Kukielka-Budny, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 6, 2026
Machine Learning to Predict Remission Between Six and 24 Months in Rheumatoid Arthritis: Insights from the JAK-pot CollaborationZubeyir Salis, Denis Mongin, Denis Choquette, et al.
Rheumatology (Oxford, England)|December 18, 2015
Effectiveness and long-term retention of anti-tumour necrosis factor treatment in juvenile and adult patients with juvenile idiopathic arthritis: data from Reuma.ptAna F Mourão, Maria J Santos, José A Melo Gomes, et al.
Acta Reumatologica Portuguesa|July 12, 2012
Portuguese recommendations for the use of biological therapies in patients with axial spondyloarthritis--December 2011 updatePedro Machado, Alexandra Bernardo, Ana Rita Cravo, et al.
Annals of the Rheumatic Diseases|September 13, 2022
After JAK inhibitor failure: to cycle or to switch, that is the question - data from the JAK-pot collaboration of registriesManuel Pombo-Suarez, Carlos Sanchez-Piedra, Juan Gómez-Reino, et al.
Annals of the Rheumatic Diseases|May 30, 2024
Factors associated with disease flare following SARS-CoV-2 vaccination in people with inflammatory rheumatic and musculoskeletal diseases: results from the physician-reported EULAR Coronavirus Vaccine (COVAX) RegistryBayram Farisogullari, Saskia Lawson-Tovey, Kimme L Hyrich, et al.
RMD Open|November 3, 2024
Impact of patient characteristics on ASDAS disease activity state cut-offs in axial spondyloarthritis: results from nine European rheumatology registriesLykke M Ørnbjerg, Stylianos Georgiadis, Tore K Kvien, et al.
RMD Open|November 8, 2018
Mixed connective tissue disease: state of the art on clinical practice guidelinesBenjamin Chaigne, Carlo Alberto Scirè, Rosaria Talarico, et al.
Pageof 20